Comparison of the efficacy and safety of insulin degludec between type 1 and type 2 diabetes

被引：0
|
作者：
Fujiya, Atsushi [1 ]
Shimauchi, Risa [1 ]
Kato, Makoto [1 ]
Miura, Emiri [1 ]
Shibata, Taiga [1 ]
Sobajima, Hiroshi [1 ]
机构：
[1] Ogaki Municipal Hosp, Ogaki, Gifu, Japan
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2016年 / 120卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PD-117
引用
收藏
页码：S128 / S128
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus
    Evans, Marc
    Chubb, Barrie
    Gundgaard, Jens
    DIABETES THERAPY, 2017, 8 (02) : 275 - 291
  • [42] Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety
    Paola Ponzani
    Cesare Berra
    Alessandra Di Lelio
    Paola Del Sindaco
    Chiara Di Loreto
    Francesco Reggiani
    Giuseppe Lucisano
    Maria Chiara Rossi
    Diabetes Therapy, 2018, 9 : 2209 - 2218
  • [43] EFFICACY OF INSULIN DEGLUDEC AFTER SWITCHING FROM INSULIN GLARGINE OR INSULIN DETEMIR IN YOUNG PERSONS WITH TYPE 1 DIABETES
    Urakami, T.
    Kuwabara, R.
    Habu, M.
    Okuno, M.
    Suzuki, J.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S235 - S236
  • [44] Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety
    Ponzani, Paola
    Berra, Cesare
    Di Lelio, Alessandra
    Del Sindaco, Paola
    Di Loreto, Chiara
    Reggiani, Francesco
    Lucisano, Giuseppe
    Rossi, Maria Chiara
    DIABETES THERAPY, 2018, 9 (06) : 2209 - 2218
  • [45] Effectiveness of insulin degludec/liraglutide versus insulin degludec/insulin aspart in Japanese patients with type 2 diabetes
    Oya, Junko
    Nakagami, Tomoko
    Hasegawa, Yukiko
    Kondo, Yuichiro
    Katamine, Aki
    Shimizu, Mika
    Kubota, Ryo
    Suda, Rika
    Babazono, Tetsuya
    DIABETOLOGY INTERNATIONAL, 2024, 15 (02) : 237 - 243
  • [46] Efficacy and safety of fast-acting insulin aspart compared with insulin aspart, both with insulin degludec with or without metformin, in adults with type 2 diabetes
    Lane, W.
    Bozkurt, K.
    Favaro, E.
    Jang, H. C.
    Kjaersgaard, M. I. S.
    Oviedo, A.
    Rose, L.
    Senior, P.
    Sesti, G.
    Soto Gonzalez, A.
    Franek, E.
    DIABETOLOGIA, 2019, 62 : S10 - S11
  • [47] Efficacy and Safety of Insulin Aspart 30 and Insulin Degludec/Aspart vs. Basal Insulin in Patients with Type 2 Diabetes: A Meta-analysis
    Mishriky, Basem M.
    Tanenberg, Robert J.
    Cummings, Doyle M.
    DIABETES, 2017, 66 : A252 - A252
  • [48] Efficacy and safety of once-weekly insulin icodec versus once-daily insulin degludec in type 1 diabetes: ONWARDS 6
    Russell-Jones, D.
    Babazono, T.
    Cailleteau, R.
    Engberg, S.
    Irace, C.
    Kjaersgaard, M. I. S.
    Mathieu, C.
    Rosenstock, J.
    Woo, V.
    Klonoff, D. C.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S7 - S8
  • [49] Real-world efficacy and safety of insulin degludec with mealtime rapid-acting insulin in type 1 diabetes in Indian pediatric population
    Kochar, Inderpal Singh
    Sethi, Aashish
    INTERNATIONAL JOURNAL OF PEDIATRIC ENDOCRINOLOGY, 2018,
  • [50] Effectiveness of insulin degludec/liraglutide versus insulin degludec/insulin aspart in Japanese patients with type 2 diabetes
    Junko Oya
    Tomoko Nakagami
    Yukiko Hasegawa
    Yuichiro Kondo
    Aki Katamine
    Mika Shimizu
    Ryo Kubota
    Rika Suda
    Tetsuya Babazono
    Diabetology International, 2024, 15 : 237 - 243
12345